VNRXVolitionRx Limited
2.675USD-1.65%Mkt Cap: 22.28M USDP/E: Last update: 2026-06-01

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offer…

Indicators:|

Key Statistics

Company
Market Cap22.28M USD
Enterprise Value24.85M USD
Revenue (TTM)1.73M USD
Gross Profit1.73M USD
Net Income (TTM)-23.36M USD
Revenue/Share0.3230 USD
Last Price2.675 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees75
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)0.25
PEG
EV/EBITDA-1.20
EV/Revenue14.39
P/S12.88
P/B-9.82
EPS (TTM)-4.25
EPS (Forward)10.80
52W Range
1.9105% of range18.80
52W High18.80 USD
52W Low1.910 USD
Profitability
Gross Margin100.00%
Oper. Margin-1077.86%
EBITDA Margin0.00%
Profit Margin-1352.16%
ROE68.20%
ROA-338.45%
Growth
Revenue Growth133.20%
Earnings Growth
Cash Flow & Leverage
Operating CF-19.68M USD
CapEx (TTM)89.56K USD
FCF Margin-492.95%
FCF Yield-38.21%
Net Debt10.35M USD
Net Debt/EBITDA-0.50
Balance Sheet
Debt/Equity-0.33
Current Ratio0.17
Quick Ratio0.12
Book Value/Sh-0.2720 USD
Cash/Share0.1410 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:20
Split DateApr 28, 2026
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)20.21 USD
Target Range16.83 USD24.00 USD
# Analysts4
Ownership
Shares Out.8.33M
Float6.88M
Insiders13.18%
Institutions16.85%
Short Interest
Short Ratio1.3d
Short % Float3.53%
Short % Out.3.33%
Shares Short269.07K
Short (prev mo.)403.72K
Technical
SMA 503.072 (-12.9%)
SMA 2006.719 (-60.2%)
Beta1.03
S&P 52W Chg27.94%
Avg Vol (30d)267.17K
Avg Vol (10d)275.15K
Technical Indicators
RSI (14)49.5
MACD-0.0358
MACD Signal-0.1422
MACD Hist.+0.1064
BB Upper3.108 USD
BB Middle2.486 USD
BB Lower1.864 USD
BB Width50.03%
ATR (14)0.3012 USD
Vol Ratio (20d)0.50x